I. INTRODUCTION
Glioblastoma multiforme is the most malignant disease among the brain tumors and is well characterized by pronounced hypercellularity, pleomorphism, numerous mitoses, foci of necrosis and palisading, and excessive vascularization with morphological alterations in blood vessels [1] [2] [3] . About 80% of malignant primary brain tumors are gliomas. Although brain tumors can occur at any age, they are most common in children of 3 to 12 years age and in adults of 40 to 70 years age. The majority of patients with this grade of tumor do not respond to surgical resection, radiation therapy and adjuvant chemotherapy. Achievement of effective new treatments can be possible only through better understanding of the molecular mechanism of disease.
BBB protects brain from a changing composition of the blood and restrict the paracellular diffusion of hydrophilic molecules due to highly specialized endothelial cells which contain an elaborate network of complex tight junctions (TJs) between the endothelial cells (4, 5) . In glioma and other pathological conditions of brain, blood vessels lose their BBB nature, which results in severe edema [6] .
In recent years, reports have shown tight junction proteins were associated with epithelial and endothelial cells. TJ-associated proteins include cytoplasmic peripheral membrane proteins and integral membrane proteins. Cytoplasmic peripheral membrane proteins ZO-1 and ZO-2 belongs to MAGUK family [7] and Integral membrane proteins occluding [8, 9] and the claudins, which comprise a novel gene family of four transmembrane TJ proteins with no sequence homology to occludin [10, 11] .
The experiment of transfection of fibroblasts with claudins induced in absence of occludin, proved that claudins are important for TJ induction. To date, 24 members of the claudin family proteins with different tissue distribution have been described [20] . In the CNS, claudin-1 and claudin-5 have been detected in BBB endothelium at the protein level [12] [13] [14] . Furuse et al. [10] described in a Northern blot analysis the expression of claudin-1 and the absence of claudin-2 in whole brain preparations [15] .
In the present study we investigated expression of claudin 3 transcription levels in low grade and high grade glioma cell lines. Real Time PCR and western blot methods were employed to asses mRNA expression levels. In this study we have used cell lines C6, U373, U87 MG, U118 and T98, and ECV 304 was used as control. The current study suggested that a down regulation of blood brain barrier component claudin 3 was observed in high grade cell lines.
II. MATERIALS AND METHODS

Glioma Cell cultures
The malignant glioma cell lines comprising C6 (lower grade), U118 and U373, T98MG, U87MG (higher grade) in and control cell line ECV304, used in the current study. All the cell lines were maintained in Dulbecco's modified Eagle's media [DMEM] with supplementations of 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 50 U/mL penicillin, and 50 μg/mL streptomycin. All the cell lines were grown up to 80% confluence in 75 cm 2 culture flasks at 37°C in incubator with 5% Co2. Cell line sub culturing was done for 48 hours trypsinization method, centrifuging and resuspending in fresh DMEM. Finally, the cultured cells were scraped from culture flasks and single cell suspensions were prepared in TRIZOL reagent (Invitrogen) by passing pieces of cells through series of sequentially smaller hypodermic needles (22-30 gauge) and stored at -80 0 c until processed further for RNA and protein isolations.
Cell viability assays
The viability of cultured was determined by standard tryphan blue exclusion test, where 10μl trypan blue solutions was added to 10 µl cell suspension containing approximately 2×10 4 cells at logarithmic growth phase. The counting scores of stained and unstained cells on hemocytometer were based to estimate the cell survival.
RNA extractions and Real-time polymerase chain reaction analysis
Total RNA from cultured cells (approximately 10 6 cells) was extracted using TRIZOL reagent (Invitrogen) according to manufacturer's instructions. After DNaseI treatment, all RNAs were reversetranscribed into cDNAs with Superscript II reverse transcriptase (Invitrogen, USA) and oligo (dT) primers in accordance to the manufacturer's protocol instructions. The specific mRNA quantities of claudin 3 in all cDNA samples were determined by Real-time reverse transcriptase (RT)-polymerase chain reaction (PCR) method using ABI Prism 7000 Sequence Detection System. Each 20 µl reaction mixture contained 12.5 µl of 2X Power SYBR Green PCR Master Mix (Applied Biosystems), 5 µl of cDNA, and 10 pm primer pairs (listed in Table 1 ). To counterbalance variations in PCR efficiency, standard curve analysis with serially diluted pooled cDNAs was done for primer sets in each reaction set up. PCR reaction conditions included 2 mins at 95°C for initial denaturing, then 40 cycles of 95°C for 20 s, 63°C for 30 s, and 72°C for 30s annealing, followed by melting analyses from 55 to 95°C. RT-PCR reactions of claudin 3 for each sample were done in triplicates in 96-well plates. Melting curves were checked to verify the melting temperatures of PCR amplicons. Additionally, PCR amplicons from the real-time master plate were subjected to electrophoresis on 2% agarose gel to confirm the success of PCR reaction. GAPDH was used as reference gene. The relative expression levels for claudin 3 was estimated according to the ΔΔCt approximation method by normalizing estimates of claudin 3 to GAPDH levels [XN=2(-Δ Ct), where ΔCt= (Ct of CDLN3 -Ct of GAPDH)]. The normalized levels of the transcripts in glioma cell lines were then expressed in the form of 2(-ΔΔCt).
Preparation of glioma cell lines lysates
Cell lines were washed twice with ice-cold phosphate buffered saline (PBS) and scraped into 3-5 volumes of RIPA buffer. After the sonication process for few min, insoluble material was eliminated by centrifuging at 14000g for 10 min at 4 o C. The whole cell lysate was collected and frozen at -80 0 C before used for protein analysis. The protein concentrations in cell lysates were determined using UV Spectrophotometer.
Western immunoblotting analysis
Cell lysates were subjected to electrophoresis on SDS-polyacrylamide gels and transferred onto nitrocellulose membrane. After blocking this membrane in non-fat dry milk (5%) in Tris Buffered Saline (TBS) (10mM Tris (pH 7.5), 150 mM NaCl) for 1 h at room temperature, membrane was incubated with in primary antibody claudin 3 over night. Blot was again incubated with secondary antibody goat anti-mouse IgG diluted conjugated to alkaline phosphatase (ALP) for one hour at room temperature. Immunoreactivity was done by incubating the blots with BCIP-NBT solution.
Statistical analysis
All continuous variable data derived from sets of gene expression experiments were represented as mean and standard deviation. The relative differences between the gene expression levels were compared with standard two-tailed t-test using InStat Software approach (GraphPad, San Diego, CA). Statistically significant difference between the expression of individual gene expression levels was considered when a p value <0.05 was obtained. 
III. FIGURES AND TABLES
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IV. RESULTS
In order to examine the claudin 3 expression status in glioma, we have analyzed the gene expression levels of claudin 3 in low grade and high grade glioma cell lines. Figure 1 reveals that, although, a significant down regulation of CDLN3 expression was observed in glioma cell lines of higher grade cell lines i.e. 0.275 ± 0.02 in U373, 0.245±0.03 in U87MG, 0.291± 0.02 in U118, 0.211± 0.02 in T98 compared to their lower grade counterpart i.e. C6 (0.81±0.08) and ECV 304 control cell lines (1.32 ± 0.02).
Western blot analysis results also showed the down regulated expression of claudin 3 protein in high grade cell lines to low grade cell lines. [Fig: 2a&b] . The results of Real Time PCR and Western blot analysis in glioma cell lines supports the down regulated expression of claudin 3 significantly is associated with high grade glioma progression.
The results of Real Time PCR analysis in low grade and high grade glioma cell lines reveals the down regulated expression of claudin 3 significantly is associated with high grade glioma progression.
V. Discussion
Tight junction proteins are playing important role in barrier and fence functions in epithelial and endothelial cells. Claudin 3 expression was observed in epithelial cells of Liver, pancreas, stomach and intestine [16] . Freeze fracture Studies have shown that claudin 3 of TJs in BBB was associated with either the P-or the E-face of the endothelial cell [17] [18] [19] . Claudin 3 forms TJs associated exclusively with the P-face as is the case for claudin-1, when L-fibroblasts transfected with claudin-3 [20] .
In current study we have investigated the expression pattern of tight junction protein claudin3 in low grade and high grade glioma cell lines. This study was undertaken to understand the biological significance of altered tight junction protein expression in glioma progression. Several studies have reported the CDLN roles in forming TJs [21] , conferring ionic selectivity [22] and functioning as a barrier [23] , but only few reports have been published on the expression of CDLNs in glioma.
Study by Wolburg et al. shown that maturation of the BBB was not complete at younger age. Younger rats about 3 weeks have developed neutrophil-mediated inflammation in the CNS, whereas older rats have not shown any inflammation at the BBB when these rats were injected LPS [24] . Reports have shown other TJ proteins like claudin-5, occluding expression levels were observed in cerebral vessels of EAE, electron microscopic investigations also supported cerebral vessels were characterized by the presence of inflammatory cells and altered TJ proteins were irregularly formed [24] . Studies have shown detectable proteins levels of claudin-5 and occluding, but claudin 3 expression was absent.
Blood brain barrier leakage and edema formation are important hallmarks of inflammation in the CNS and have been involved in the pathogenesis of EAE [3] . Studies have shown particularly claudin 3 expression was down regulated in glioma as well as in EAE vessels. In our study, Real Time PCR and western blot analysis revealed down regulation of claudin 3 expression in high grade glioma compared to low grade glioma.
V. Conclusion
The key finding of the current study is that loss of claudin 3 expression is associated with the progression of malignant gliomas. Our results showed that claudin 3 is down regulated in high grade glioma particularly in glioblastoma multiforme. Results of quantitative Real Time PCR and western blot analysis demonstrated that the expression level of claudin 3 significantly correlates with the World Health Organization histological grades of the glioma. Taken together, these results suggest that claudin 3 is a significant predictor of glioma and could be a potential target for glioma therapy.
